Evaxion A EVAX
NASDAQ EVAX
$3.16 -0.12 (-3.69%)
As of: Oct 1, 2026 · 11:50 AM EDT

Evaxion A (EVAX) Other Operating Expenses (2023)

Updated

Evaxion A (EVAX) posted Other Operating Expenses of $11.35 million for Q2 2023.

Analysis

Evaxion A (EVAX) Other Operating Expenses (2023) Analysis & Trends

For FY2022, Evaxion A's Other Operating Expenses came in at $50.53 million, down 2.2% from FY2021.

  • In prior years, Evaxion A's Other Operating Expenses was $51.67 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Evaxion A 21.02 Mn -45.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 11.35 Mn
API Access

Evaxion A Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=EVAX&period=max&api_key=YOUR_API_KEY